Insider Transactions in Q2 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$735,900
$669.51 P/Share
|
|
Jun 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
May 24
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
23,077
-6.68%
|
-
|
|
May 17
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,543
-0.39%
|
$2,349,009
$663.18 P/Share
|
|
May 16
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,457
-9.43%
|
$4,184,136
$648.31 P/Share
|
|
May 16
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.74%
|
$1,790,000
$179.13 P/Share
|
|
May 02
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$721,600
$656.97 P/Share
|
|
May 02
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
|
May 02
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$65,000
$650.58 P/Share
|
|
Apr 11
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,862
-0.69%
|
$1,366,708
$734.5 P/Share
|
|
Apr 08
2022
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,606
-9.7%
|
$4,126,016
$736.21 P/Share
|
|
Apr 08
2022
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,450
+11.26%
|
$3,076,850
$413.05 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,138
-9.01%
|
$4,517,568
$736.21 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+10.29%
|
$3,120,000
$390.79 P/Share
|
|
Apr 08
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
325
-0.11%
|
$239,200
$736.48 P/Share
|
|
Apr 07
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$899,000
$725.0 P/Share
|
|
Apr 07
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Apr 07
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,114
-23.23%
|
$3,687,194
$721.1 P/Share
|
|
Apr 07
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,175
-3.89%
|
$841,300
$716.09 P/Share
|
|
Apr 07
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Apr 06
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
302
-0.24%
|
-
|
|
Apr 06
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
2,653
-19.18%
|
$1,883,630
$710.04 P/Share
|
|
Apr 05
2022
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
4,461
-24.39%
|
$3,167,310
$710.05 P/Share
|
|
Apr 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$69,300
$693.17 P/Share
|
|
Apr 01
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,114
-1.38%
|
$3,538,888
$692.65 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$701,000
$701.82 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
316
-0.54%
|
$220,568
$698.74 P/Share
|